Site icon TheVoiceOfJoyce

TheVoiceOfJoyce No regulation, paying to have the “right” scientists review your product, controlling the message and always obscuring and giving misinformation so no link appears about the harmfulness of your product. Why? In the interest of maximizing profits, both Syngenta and Chevron, knew there was a link between Parkinson’s and their product Paraguat and created a misinformation campaign around any links to the product it’s ability to cross the blood brain barrier. Parkinson’s is one of the top killers in the US, yet, without an aggressive EPA, millions can be exposed to its fumes. It can’t be ingested, it’s toxic. It’s used on fields to kill weeds, it’s sprayed from planes and over our ubiquitous food staples. For 50 yrs, the companies downplayed the tremors noted and the products effects on the Public, all to keep the profits flowing. Like Glycopvhosphates, they’re toxic. They’re causing diseases in humans. Yet, our Market Society, pushed by the GOP, advocates for Profits . We the People are expendable . Do you think you and your family are disposable? If you value life,don’t vote for TRUMPSGOP. TrumpsGop supports Unregulated Big Business,their constituents, not “We the People”!

jaslvr

www.theguardian.com/us-news/2022/oct/20/syngenta-weedkiller-pesticide-parkinsons-disease-paraquat-documents

the Guardian has reviewed hundreds of pages of these documents in a reporting collaboration with the New Lede.

Among the revelations from the documents: scientists with Syngenta predecessor Imperial Chemical Industries (ICI) and Chevron Chemical were aware in the 1960s and 70s of mounting evidence showing paraquat could accumulate in the human brain.

When Syngenta’s own internal research showed adverse effects of paraquat on brain tissue, the company withheld that information from regulators while downplaying the validity of similar findings being reported by independent scientists.

In addition, the records show company scientists were aware of evidence that exposure to paraquat could impair the central nervous system (CNS), triggering tremors and other symptoms in experimental animals similar to those suffered by people with Parkinson’s. A 1975 Chevron communication speaks of concerns about allegations of “permanent CNS effects from paraquat”.

At a meeting of Syngenta executives in 2009, paraquat’s possible connection to Parkinson’s was highlighted Composite: The Guardian

And as independent researchers continued to find more and more evidence that paraquat may cause Parkinson’s, the documents describe what Syngenta called an “influencing” strategy “that proactively diffuses [sic] the potential threats that we face” and seeks to “maintain and safeguard paraquat registrations”, referring to their regulatory approvals. The strategy “must consider how best to influence academia, and regulatory and NGO environments”.

Exit mobile version